198 related articles for article (PubMed ID: 27105909)
61. Acute phase serum amyloid A protein increases high density lipoprotein binding to human peripheral blood mononuclear cells and an endothelial cell line.
Hayat S; Raynes JG
Scand J Immunol; 2000 Feb; 51(2):141-6. PubMed ID: 10652160
[TBL] [Abstract][Full Text] [Related]
62. Development and Characterization of Monoclonal Antibodies Against Nitro-
Divya G; Jayaprakash NS; Venkataraman K
Monoclon Antib Immunodiagn Immunother; 2018 Aug; 37(4):167-174. PubMed ID: 30132720
[TBL] [Abstract][Full Text] [Related]
63. Serum amyloid A is independently associated with metabolic risk factors but not with early atherosclerosis: the Cardiovascular Risk in Young Finns Study.
Jylhävä J; Haarala A; Eklund C; Pertovaara M; Kähönen M; Hutri-Kähönen N; Levula M; Lehtimäki T; Huupponen R; Jula A; Juonala M; Viikari J; Raitakari O; Hurme M
J Intern Med; 2009 Sep; 266(3):286-95. PubMed ID: 19702793
[TBL] [Abstract][Full Text] [Related]
64. Degradation of amyloid-related serum protein SAA by a component present in rabbit and human serum.
Skogen B; Natvig JB; Bøorresen AL; Berg K
Scand J Immunol; 1980; 11(6):643-8. PubMed ID: 6777866
[TBL] [Abstract][Full Text] [Related]
65. Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease.
Cabana VG; Gidding SS; Getz GS; Chapman J; Shulman ST
Pediatr Res; 1997 Nov; 42(5):651-5. PubMed ID: 9357939
[TBL] [Abstract][Full Text] [Related]
66. Paradoxical effects of SAA on lipoprotein oxidation suggest a new antioxidant function for SAA.
Jayaraman S; Haupt C; Gursky O
J Lipid Res; 2016 Dec; 57(12):2138-2149. PubMed ID: 27744369
[TBL] [Abstract][Full Text] [Related]
67. Lower serum paraoxonase-1 activity is related to higher serum amyloid a levels in metabolic syndrome.
Kappelle PJ; Bijzet J; Hazenberg BP; Dullaart RP
Arch Med Res; 2011 Apr; 42(3):219-25. PubMed ID: 21722818
[TBL] [Abstract][Full Text] [Related]
68. Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits.
Yin RX; Wu DF; Miao L; Htet Aung LH; Cao XL; Yan TT; Long XJ; Liu WY; Zhang L; Li M
Biofactors; 2013; 39(3):315-25. PubMed ID: 23355348
[TBL] [Abstract][Full Text] [Related]
69. Influence of serum amyloid A protein on high-density lipoprotein in chronic inflammatory disease.
Kumon Y; Suehiro T; Ikeda Y; Yoshida K; Hashimoto K; Ohno F
Clin Biochem; 1993 Dec; 26(6):505-11. PubMed ID: 8124866
[TBL] [Abstract][Full Text] [Related]
70. The role of serum amyloid A and sphingosine-1-phosphate on high-density lipoprotein functionality.
Prüfer N; Kleuser B; van der Giet M
Biol Chem; 2015 Jun; 396(6-7):573-83. PubMed ID: 25252751
[TBL] [Abstract][Full Text] [Related]
71. Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA).
Marhaug G; Sletten K; Husby G
Clin Exp Immunol; 1982 Nov; 50(2):382-9. PubMed ID: 7151331
[TBL] [Abstract][Full Text] [Related]
72. Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasma.
DiDonato JA; Huang Y; Aulak KS; Even-Or O; Gerstenecker G; Gogonea V; Wu Y; Fox PL; Tang WH; Plow EF; Smith JD; Fisher EA; Hazen SL
Circulation; 2013 Oct; 128(15):1644-55. PubMed ID: 23969698
[TBL] [Abstract][Full Text] [Related]
73. Protein-protein interaction heterogeneity of plasma apolipoprotein A1 in nephrotic syndrome.
Santucci L; Candiano G; Petretto A; Pavone B; Bruschi M; Gusmano R; Federici G; Urbani A; Ghiggeri GM
Mol Biosyst; 2011 Mar; 7(3):659-66. PubMed ID: 21416664
[TBL] [Abstract][Full Text] [Related]
74. The function, composition, and particle size of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndrome patients.
Cho KH; Park SH; Park JE; Kim YO; Choi I; Kim JJ; Kim JR
Clin Biochem; 2008 Jan; 41(1-2):56-64. PubMed ID: 17996200
[TBL] [Abstract][Full Text] [Related]
75. The acute-phase protein serum amyloid A induces endothelial dysfunction that is inhibited by high-density lipoprotein.
Witting PK; Song C; Hsu K; Hua S; Parry SN; Aran R; Geczy C; Freedman SB
Free Radic Biol Med; 2011 Oct; 51(7):1390-8. PubMed ID: 21784147
[TBL] [Abstract][Full Text] [Related]
76. Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes.
Han CY; Chiba T; Campbell JS; Fausto N; Chaisson M; Orasanu G; Plutzky J; Chait A
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1806-13. PubMed ID: 16709944
[TBL] [Abstract][Full Text] [Related]
77. High-Density Lipoprotein (HDL) Counter-Regulates Serum Amyloid A (SAA)-Induced sPLA2-IIE and sPLA2-V Expression in Macrophages.
Zhu S; Wang Y; Chen W; Li W; Wang A; Wong S; Bao G; Li J; Yang H; Tracey KJ; D'Angelo J; Wang H
PLoS One; 2016; 11(11):e0167468. PubMed ID: 27898742
[TBL] [Abstract][Full Text] [Related]
78. Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A.
Aguilera JJ; Zhang F; Beaudet JM; Linhardt RJ; Colón W
Biochimie; 2014 Sep; 104():70-80. PubMed ID: 24878279
[TBL] [Abstract][Full Text] [Related]
79. Serum amyloid A and atherosclerosis.
Getz GS; Krishack PA; Reardon CA
Curr Opin Lipidol; 2016 Oct; 27(5):531-5. PubMed ID: 27579547
[TBL] [Abstract][Full Text] [Related]
80. Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk.
Zewinger S; Drechsler C; Kleber ME; Dressel A; Riffel J; Triem S; Lehmann M; Kopecky C; Säemann MD; Lepper PM; Silbernagel G; Scharnagl H; Ritsch A; Thorand B; de las Heras Gala T; Wagenpfeil S; Koenig W; Peters A; Laufs U; Wanner C; Fliser D; Speer T; März W
Eur Heart J; 2015 Nov; 36(43):3007-16. PubMed ID: 26248570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
